BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 241 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,551,877 | -15.6% | 504,528 | 0.0% | 0.14% | -13.1% |
| Q1 2023 | $4,207,764 | -45.5% | 504,528 | -25.0% | 0.16% | -45.2% |
| Q4 2022 | $7,722,653 | +75.3% | 672,705 | +92.4% | 0.29% | +62.2% |
| Q3 2022 | $4,405,000 | +50.1% | 349,570 | +26.0% | 0.18% | +56.5% |
| Q2 2022 | $2,935,000 | -8.2% | 277,434 | +41.1% | 0.12% | +2.7% |
| Q1 2022 | $3,197,000 | +44.9% | 196,625 | -56.2% | 0.11% | +31.8% |
| Q4 2017 | $2,206,000 | +30.2% | 449,255 | +39.0% | 0.08% | +39.3% |
| Q3 2017 | $1,694,000 | – | 323,255 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 864,916 | $13,674,000 | 13.71% |
| Sarissa Capital Management LP | 4,261,000 | $67,366,000 | 5.36% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,920,733 | $30,367,000 | 4.18% |
| HealthCor Management, L.P. | 3,248,100 | $51,352,000 | 2.05% |
| Parkman Healthcare Partners LLC | 351,961 | $5,565,000 | 1.22% |
| Bain Capital Public Equity Management II, LLC | 1,560,730 | $24,675,000 | 1.06% |
| Baker Brothers Advisors | 12,710,818 | $200,958,000 | 0.88% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,835,000 | $44,821,000 | 0.80% |
| Biondo Investment Advisors, LLC | 265,840 | $4,203,000 | 0.72% |
| EAM Global Investors LLC | 157,065 | $2,483,000 | 0.69% |